In preclinical studies on pemphigus vulgaris, T cells were engineered to express the autoantigen desmoglein 3 (Dsg3) on their surface, enabling precise recognition and destruction of B cells producing anti-Dsg3 autoantibodies. The gene discussed is DSG3; the disease is pemphigus vulgaris.